|Last Price||Today's Change||52-Week Range||Trading Volume|
|24.64||0.52 (+2.16%)||21.51 - 27.52||26.9 thousand (Below Avg)|
Market data as of 3:49PM 02/08/16. Quotes are delayed by at least 15 min.
FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD)
02/03/2016 8:36 PM ET
FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)
01/27/2016 12:00 PM ET